Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis

19Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Patients and members of staff from a haemodialysis unit were tested for markers of infection with human T cell lymphotropic virus type III (HTLV-III), the virus associated with the acquired immune deficiency syndrome (AIDS). An enzyme linked immunosorbent assay showed eight of 100 patients to have antibodies to HTLV-III. In five of these patients past or present infection with HTLV-III was confirmed by Western blot analysis or detection of HTLV-III antigens in lymphocyte cultures, or both. Investigation of other risk factors for AIDS showed that the putative source of HTLV-III was unrelated to dialysis in two patients whereas blood transfusion was the most likely cause of contamination in the others. No member of staff gave a positive result in the enzyme linked immunosorbent assay. Nosocomial transmission of HTLV-III seems unlikely if precautions similar to those recommended for the control of hepatitis B infection are applied. © 1986, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Goldman, M., Liesnard, C., Vanherweghem, J. L., Dolle, N., Toussaint, C., Sprecher, S., … Thiry, L. (1986). Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. British Medical Journal (Clinical Research Ed.), 293(6540), 161–162. https://doi.org/10.1136/bmj.293.6540.161

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free